news

UC-Davis has published a placebo controlled clinical study benefits of Synoxyl® AZ

Clinical Effects of Synoxyl® AZ: Sytheon collaborated with UC-Davis researchers on this study which delivers significant improvement in photoaging related skin benefits as well as skin sensitivity through well explored mechanisms of action. The skin benefits were explored through a double-blind placebo controlled randomized clinical study. There was a significant decrease in average wrinkle severity (p=0.019; Mean=-25.7% change), total wrinkle volume (p=0.003; Mean=-30.1 % change), pigment intensity (p=0.021; Mean=-25.6% change), and redness intensity (p=0.035; Mean=-20.7% change) in the AZ group by 8 weeks compared to the placebo. Acetyl zingerone is well tolerated with daily use. No itching, burning, or stinging was noted by study participants. Additionally, AZ treatment has maintained skin microbiome diversity with >20% increase in skin friendly staphylococcus epidermidis.

About Synoxyl® AZ: A multifunctional ingredient whose design was inspired by Zingerone from ginger in nature, AZ works through mechanisms of action recently revealed in academic research to provide skincare benefits around the clock. AZ incorporates both proactive and reactive functionalities to provide 24/7 protection and treatment of skin damage caused by continual exposure to sun, pollution or blue light. AZ’s unique molecular structure provides immediate and long-lasting benefits by quenching and scavenging even the most reactive ROS with high efficiencies as compared to conventional antioxidants. AZ is photochemically stable in contrast to many conventional antioxidants. AZ can be used in skincare formulations either alone or in combination with conventional antioxidants to obtain a higher magnitude of benefits than can be achieved today with current offerings.

For more information, please send your inquiry to info@sytheonltd.com

Sytheon’s CEO to Speak at NYSCC Acne Care Symposium

Sytheon’s CEO to Speak at NYSCC Acne Care Symposium

Ratan K. Chaudhuri, Ph.D., President and CEO at Sytheon, will discuss key strategic targets for mitigating acne-affected skin. Sytheon, a...

by Drew FrantzenMay 19, 2023
Read More
Sytheon is excited to announce a publication on Synergistic…

Sytheon is excited to announce a publication on Synergistic…

Sytheon is excited to announce a publication on Synergistic Anti-Inflammatory Effects of Isosorbide Fatty Acid Diesters in Cytokine-Induced Tissue Culture...

by hostingagencyusDecember 6, 2022
Read More
Founder and CEO Dr. Ratan Chaudhuri has been named as a top 10…

Founder and CEO Dr. Ratan Chaudhuri has been named as a top 10…

Founder and CEO Dr. Ratan Chaudhuri has been named as a top 10 inspiring business leader by Inc. magazine to...

by hostingagencyusOctober 6, 2022
Read More
Sytenol® A is Accepted for Use in the Chinese Market

Sytenol® A is Accepted for Use in the Chinese Market

We are pleased to announce that Sytenol® A (Bakuchiol) has been successfully notified as a medium-low risk new cosmetic ingredient...

by hostingagencyusAugust 31, 2022
Read More
Sytheon Announces Relocation and Expansion of New Corporate Headquarters

Sytheon Announces Relocation and Expansion of New Corporate Headquarters

Sytheon relocates its headquarters to 10 Waterview Blvd, Parsippany, NJ. The move to a new state-of-the-art facility stems from Sytheon’s...

by hostingagencyusAugust 1, 2022
Read More
Bakuchiol – A natural alternative to Retinol shows holistic treatment approach…

Bakuchiol – A natural alternative to Retinol shows holistic treatment approach…

Bakuchiol – A natural alternative to Retinol shows holistic treatment approach for facial aging based on its multidirectional activity Beiersdorf...

by hostingagencyusJune 3, 2022
Read More